Loss of ribosomal protein uL14 enables tumor escape from T cell immunosurveillance
Open Access
- 7 August 2025
- journal article
- Published by Oxford University Press (OUP) in NAR Cancer
- Vol. 7 (3)
Abstract
The presentation of peptides on HLA molecules is essential to CD8+ T cell responses. Here, we show that loss of uL14 significantly downregulates the expression of antigen processing and presentation (APP) components in melanoma cell lines. Peptides generated following knockdown show different characteristics, with altered peptide charge, and differences in anchor residue positions. These peptides also have lower predicted binding to the HLA alleles and a shorter predicted HLA-peptide complex half-life. These result in a functional difference in APP, and knockdown of uL14 causes a reduction in the ability of CD8+ T cells to recognize and kill melanoma cells in a co-culture assay. Together, our data suggest that loss of uL14 alters the peptide pool available for presentation and thus may act as an escape mechanism from tumor immune surveillance.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (OCENW-M20-373)
- Mark Foundation For Cancer Research (21-053-ASP)
- KWF (13878)
- Dutch Ministry of Health, Welfare and Sport
This publication has 44 references indexed in Scilit:
- P-stalk ribosomes act as master regulators of cytokine-mediated processesCell, 2024
- MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen ProcessingCell Systems, 2020
- The urgent need to recover MHC class I in cancers for effective immunotherapyCurrent Opinion in Immunology, 2016
- Simple and Reproducible Sample Preparation for Single-Shot Phosphoproteomics with High Sensitivity2016
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer LiabilitiesCell, 2015
- Differential Stoichiometry among Core Ribosomal ProteinsCell Reports, 2015
- Protein synthesis regulation, a pillar of strength for innate immunity?Current Opinion in Immunology, 2015
- Peptide‐MHC class I stability is a better predictor than peptide affinity of CTL immunogenicityEuropean Journal of Immunology, 2012
- The DRiP hypothesis decennial: support, controversy, refinement and extensionTrends in Immunology, 2006
- Have we cut ourselves too short in mapping CTL epitopes?Trends in Immunology, 2006